Skip to content

Vor Biopharma Inc.

VOR· NasdaqCore metricsCIK 1817229

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -3.91%
Market cap
$1.19B
61.43M shares
Filings
466
—
—
—
-$86.73M
Q3 2026N/M FY25 yoy
-$58.44M
Q3 2026N/M FY25 yoy
-$96.56M
Q3 2026derivedN/M FY25 yoy
-$1.45
Q3 2026N/M FY25 yoy
$78.98M
Q3 2026+383.8% FY25 yoy
$1.19B
—
—
—
-12.11%
0.00%

FY2025 figures · derived

Price

$19.31+96.44%+$9.48past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$321.53MFY 2025
$321.53M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$321,532,000reported
FY 20242024-12-31$93,310,000reported
FY 20232023-12-31$94,315,000reported
FY 20222022-12-31$64,550,000reported
FY 20212021-12-31$47,529,000reported
FY 20202020-12-31$31,618,000reported

Capital returns

Dividends and buybacks · FY2020 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$0.00—$0.00—48.85M sh−60.9%—
FY2024$0.00—$0.00—124.85M sh+83.2%—
FY2023$0.00—$0.00—68.17M sh+2.7%—
FY2022$0.00—$0.00—66.37M sh+77.1%—
FY2021$0.00—$0.00—37.49M sh+7,322.4%—

Biological products, except diagnostic substances

Vor Biopharma Inc. is the 45th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Vor Biopharma Inc. · CIK 1817229 · Engraved from SEC EDGAR